InvestorsHub Logo
Followers 11
Posts 2370
Boards Moderated 0
Alias Born 06/08/2010

Re: DonShimoda post# 7668

Thursday, 05/05/2011 10:34:35 AM

Thursday, May 05, 2011 10:34:35 AM

Post# of 80490
And though these may not be a requirement,

Rida's very likely superior performances in the largest(softtissue)subpopulations(reviewed here ad nauseum in the past) have to bolster the case for overall approval.

In addition, once that happens,
it's likely to supercharge the development and acceptance of Rida in other indications.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.